why choose us

First received: November 03, 2023

Clinical Trial: AMX0035 and Progressive Supranuclear Palsy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Progressive Supranuclear Palsy

Study Type: INTERVENTIONAL


Official Title: A Phase 3 Study of Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION)

Brief Summary: ORION Trial is a trial to evaluate the efficacy and safety of AMX0035 in participants with Progressive Supranuclear Palsy (PSP), consisting of a randomized double blind placebo controlled phase, followed by an optional open-label extension phase.

Read more